[ad_1] November 1, 2018 – By Dolores Ford Investors sentiment increased to 1.74 in Q2 2018. Its up 0.74, from 1 in 2018Q1. It is positive, as 9 investors sold Keryx Biopharmaceuticals, …
Read More »EPS for Keryx Biopharmaceuticals, Inc. (KERX) Expected At $-0.13
